SPAGO Recruits a Study Coordination Director

Per-Olof Eriksson will take on the role as Study Coordination Director effective as of November 1st.

Per-Olof comes from AstraZeneca where he has held various positions as line manager and project leader within Discovery and Development for more than 15 years. He will add extensive experience from preclinial and early clinical studies and be a valuable member of the SPAGO team.